Cervical Cancer: Page 2

Dalrada Health completes cervical cancer screening kit trial
By LabPulse.com staff writers
Results from the trial were published this month in the Indian Society of Perinatology and Reproductive Biology (IJOPARB) journal. Study participants were screened for cervical cancer with cerVIA, which showed an accuracy of 91%, according to the firm. The test is patent-pending, Dalrada said.
April 24, 2022
2019 11 07 23 47 6944 Squamous Epithelial Cells Cervical 400
Dr. Elizabeth Stern: A pioneer in cytopathology screening
By Louise Gagnon
Early years
March 28, 2022
2022 03 28 17 43 9863 Pathology Pap Smear Cervical 400
Hologic receives CE Mark for Genius cervical cancer software
By LabPulse.com staff writers
The new algorithm analyzes ThinPrep Pap images to narrow tens of thousands of cells down to an AI-generated gallery to find lesions and cancer cells. This arms healthcare providers with the critical information they need to guide earlier detection and better treatment decisions for the patients in their care, the company said.
November 3, 2021
2021 11 04 18 10 3690 2021 11 04 Hologic Genius 400
How AI for cervical cancer can help achieve healthcare equity
By Michael Quick
Thanks to screening programs and improvements in technology, mortality rates have been falling in high-income countries, yet rates within these regions still can affect populations drastically differently. For example, Black women in the U.S. are two times more likely to die from cervical cancer than white women.3
October 10, 2021
2021 10 07 22 49 0009 Computer Woman Ai 400
Mel-Mont validates self-sampling kit
By LabPulse.com staff writers
Norwegian researchers tested the kit's performance in a group of 500 women at detecting rates of genital HPV infection compared to clinician-collected samples. The study found "fair agreement" of HPV positivity rates between the two methods, according to the authors. The study was published in BMC Infectious Diseases.
August 4, 2021
2020 07 29 23 56 6775 Hpv Infection 400
OptraScan launches cytology slide scanning device
By LabPulse.com staff writers
CytoSiA consists of the company's digital pathology scanner, storage, and artificial intelligence (AI) algorithms for screening and detection of cervical cancer, precancerous lesions, and atypical cells. It can scan 15 x 15-mm cytology slides at 40x magnification in less than 60 sec, according to the firm.
May 24, 2021
2019 05 08 21 57 5547 Pathology Digital Workstation 400
Hologic wins CE Mark for cervical cancer screening system
By LabPulse.com staff writers
After analyzing all cells on a ThinPrep Pap test slide, Genius Digital Diagnostics can provide a gallery view of the most diagnostically relevant images, Hologic said.
November 16, 2020
2020 06 16 21 12 7935 Artificial Intelligence Ai Hand 400
ACS cervical cancer guidelines disappoint some testing firms
By LabPulse.com staff writers
The current standard of care is to use the Pap test for women ages 21 to 29 and a combination of both the Pap test and HPV test (cotesting) for women between the ages of 30 and 65. The ACS guidelines, which were published July 30, would shift to HPV testing only, and Hologic claims this would erode access to preventative healthcare and could sow confusion among women and their healthcare providers.
July 30, 2020
2019 02 01 17 54 2200 Hologic Rsna 2018 400
National cervical cancer screening guidelines shift to primary HPV testing
By Emily Hayes
The ACS published a 2020 update to guidelines for cervical cancer screening for individuals at average risk in its publication CA: A Cancer Journal for Clinicians online July 30. Guidelines were last updated in 2012.
July 30, 2020
2020 07 29 23 56 6775 Hpv Infection 400
HPV, Pap cotesting best for cervical cancer detection in Quest study
By Melissa Busch, LabPulse.com assistant editor; Emily Hayes, editor in chief
Cotesting involves Pap and HPV screening using the same specimen. A new study of women 30 years or older by researchers at Quest Diagnostics and the University of Pittsburgh Medical Center found that cotesting outperformed HPV or Pap testing alone for detecting precancer or cancer. In the retrospective study, the researchers evaluated deidentified results for tests conducted between 2010 and 2018 by Quest in 13.6 million women; 8,059 had precancers and 1,259 were subsequently diagnosed with cervical cancer.
July 8, 2020
2019 05 17 20 14 3434 Uterus Cervix 400
Machine learning could 'transform' cervical cancer screening, NCI researchers report
By Emily Hayes
The NCI researchers described positive experiences with Cytoreader, an automated system for evaluating digital dual-stained whole-slide images for the protein biomarkers p16 and Ki-67, using data from three epidemiology studies of patients with cervical and anal cancers who were positive for human papillomavirus (HPV). The automated system assesses the number of dual-stained positive cells and flags the ones that exceed predefined cutoff points.
June 25, 2020
2020 06 24 23 01 2082 2020 06 25 Ai Dual Stain Image 400
Could cervical cancer be eliminated in 20 years?
By Kate Madden Yee
The findings suggest a way for the U.S. clinical community to actively respond to the World Health Organization's (WHO) 2018 charge to eliminate cervical cancer as a public health problem, wrote a team led by Emily Burger, PhD, of the Harvard T.H. Chan School of Public Health in Boston. The WHO's cervical cancer incidence target is four or fewer cases per 100,000 women-years.
February 10, 2020
2019 05 17 20 14 3434 Uterus Cervix 400
Previous Page
Page 2 of 3
Next Page